Cargando…
β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial
PURPOSE: To evaluate whether β-blockers were associated with a reduction in cardiovascular events or angina after Coronary Artery Bypass Graft (CABG) surgery, in otherwise stable low-risk patients during a mid-term follow-up. METHODS: We performed a post-hoc analysis of the IMAGINE (Ischemia Managem...
Autores principales: | Booij, Harmen G., Damman, Kevin, Warnica, J. Wayne, Rouleau, Jean L., van Gilst, Wiek H., Westenbrink, B. Daan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522029/ https://www.ncbi.nlm.nih.gov/pubmed/26071975 http://dx.doi.org/10.1007/s10557-015-6600-y |
Ejemplares similares
-
The Coronary Sinus Reducer for refractory angina
por: Damman, P., et al.
Publicado: (2021) -
A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling
por: Nijholt, Kirsten T., et al.
Publicado: (2023) -
AKIP1, a Cardiac Hypertrophy Induced Protein that Stimulates Cardiomyocyte Growth via the Akt Pathway
por: Yu, Hongjuan, et al.
Publicado: (2013) -
Discharge β-Blocker Use and Race after Coronary Artery Bypass Grafting
por: O’Neal, Wesley T., et al.
Publicado: (2014) -
Diagnostic and Management Strategies in Patients with Late Recurrent Angina after Coronary Artery Bypass Grafting
por: de Winter, Ruben W., et al.
Publicado: (2022)